{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:16:22Z","timestamp":1768871782590,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10067-016-3183-3","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T07:40:09Z","timestamp":1453448409000},"page":"857-861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study"],"prefix":"10.1007","volume":"35","author":[{"given":"A.","family":"Gardette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ottaviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sellam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Berenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Liot\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sibilia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Fautrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dieud\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,22]]},"reference":[{"key":"3183_CR1","unstructured":"WHO (2000) Obesity: preventing and managing the global epidemic. Tech Rep Ser 894"},{"issue":"10","key":"3183_CR2","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","volume":"6","author":"H Tilg","year":"2006","unstructured":"Tilg H, Moschen AR (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6(10):772\u2013783","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"3183_CR3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrrheum.2009.232","volume":"5","author":"U Muller-Ladner","year":"2009","unstructured":"Muller-Ladner U, Neumann E (2009) Rheumatoid arthritis: the multifaceted role of adiponectin in inflammatory joint disease. Nat Rev Rheumatol 5(12):659\u2013660","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"3183_CR4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/rheumatology\/keq266","volume":"50","author":"A Stavropoulos-Kalinoglou","year":"2011","unstructured":"Stavropoulos-Kalinoglou A, Metsios G, Koutedakis Y, Kitas G (2011) Obesity in rheumatoid arthritis. Rheumatology (Oxford) 50(3):450\u2013462","journal-title":"Rheumatology (Oxford)"},{"key":"3183_CR5","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","volume":"10","author":"A Naranjo","year":"2008","unstructured":"Naranjo A, Sokka T, Descalzo M, Calvo-Al\u00e9n J, H\u00f8rslev-Petersen K, Luukkainen R, Combe B, Burmester G, Devlin J, Ferraccioli G et al (2008) Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 10:R30","journal-title":"Arthritis Res Ther"},{"key":"3183_CR6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/rheumatology\/kel124","volume":"45","author":"D Armstrong","year":"2006","unstructured":"Armstrong D, McCausland E, Quinn A, Wright G (2006) Obesity and cardiovascular risk factors in rheumatoid arthritis. Rheumatology (Oxford) 45:782","journal-title":"Rheumatology (Oxford)"},{"key":"3183_CR7","first-page":"525","volume":"5","author":"L Voigt","year":"1994","unstructured":"Voigt L, Koepsell T, Nelson J, Dugowson C, Daling J (1994) Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology 5:525\u2013532","journal-title":"Epidemiology"},{"key":"3183_CR8","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/art.1780401106","volume":"40","author":"D Symmons","year":"1997","unstructured":"Symmons D, Bankhead C, Harrison B, Brennan P, Barrett E, Scott D, Silman A (1997) Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 40:1955\u20131961","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3183_CR9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/acr.21710","volume":"65","author":"S Ajeganova","year":"2013","unstructured":"Ajeganova S, Andersson M, Hafstr\u00f6m I, Group BS (2013) Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term follow up from disease onset. Arthritis Care Res 65(1):78\u201387","journal-title":"Arthritis Care Res"},{"issue":"11","key":"3183_CR10","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1002\/art.23033","volume":"56","author":"G Westhoff","year":"2007","unstructured":"Westhoff G, Rau R, Zink A (2007) Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index. Arthritis Rheum 56(11):3575\u20133582","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3183_CR11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.2007.078832","volume":"67","author":"AH Helm-van Mil van der","year":"2008","unstructured":"van der Helm-van Mil AH, van der Kooij SM, Allaart CF, Toes RE, Huizinga TW (2008) A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis 67(6):769\u2013774","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"3183_CR12","first-page":"2350","volume":"30","author":"J Kaufmann","year":"2003","unstructured":"Kaufmann J, Kielstein V, Kilian S, Stein G, Hein G (2003) Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol 30(11):2350\u20132355","journal-title":"J Rheumatol"},{"issue":"6","key":"3183_CR13","first-page":"509","volume":"19","author":"M Mirpourian","year":"2014","unstructured":"Mirpourian M, Salesi M, Abdolahi H, Farajzadegan Z, Karimzadeh H (2014) The association of body mass index with disease activity and clinical response to combination therapy in patients with rheumatoid arthritis. J Res Med Sci 19(6):509\u2013514","journal-title":"J Res Med Sci"},{"issue":"11","key":"3183_CR14","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/annrheumdis-2013-205094","volume":"73","author":"ME Sandberg","year":"2014","unstructured":"Sandberg ME, Bengtsson C, Kallberg H, Wesley A, Klareskog L, Alfredsson L, Saevarsdottir S (2014) Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis. Ann Rheum Dis 73(11):2029\u20132033","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3183_CR15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.30136","volume":"63","author":"R Klaasen","year":"2011","unstructured":"Klaasen R, Wijbrandts C, Gerlag D, Tak P (2011) Body mass index and clinical response to infliximab in rheumatoid arthritis. Arthritis Rheum 63(2):359\u2013364","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3183_CR16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/acr.21768","volume":"65","author":"E Gremese","year":"2013","unstructured":"Gremese E, Carletto A, Padovan M, Atzeni F, Raffeiner B, Giardina A et al (2013) Obesity and reduction of the response rate to anti-tumour necrosis factor alphain rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res 65(1):94\u2013100","journal-title":"Arthritis Care Res"},{"key":"3183_CR17","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/acr.21978","volume":"65","author":"L Heimans","year":"2013","unstructured":"Heimans L, van den Broek M, le Cessie S, Siegerink B, Riyazi N, Han KH, Kerstens PJ, Huizinga TW, Lems WF, Allaart CF (2013) Association of high body mass index with decreased treatment response to combination therapy in recent onset rheumatoid arthritis patients. Arthritis Care Res 65:1235\u20131242","journal-title":"Arthritis Care Res"},{"key":"3183_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/acr.21711","volume":"65","author":"MD Minno","year":"2013","unstructured":"Minno MD, Peluso R, Iervolino S, Lupoli R, Russolillo A, Scarpa R, Minno GD (2013) Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis. Arthritis Care Res 65:141\u2013147","journal-title":"Arthritis Care Res"},{"issue":"5","key":"3183_CR19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/annrheumdis-2013-204448","volume":"74","author":"L Eder","year":"2015","unstructured":"Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman D (2015) Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Ann Rheum Dis 74(5):813\u2013817","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3183_CR20","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar3841","volume":"14","author":"S Ottaviani","year":"2012","unstructured":"Ottaviani S, Allanore Y, Tubach F, Forien M, Gardette A, Pasquet B et al (2012) Body mass index influences the response to infliximab in ankylosing spondylitis. Arthritis Res Ther 14(3):R115","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3183_CR21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/rheumatology\/ket433","volume":"53","author":"E Gremese","year":"2014","unstructured":"Gremese E, Bernardi S, Bonazza S, Nowik M, Peluso G, Massara A, Tolusso B, Messuti L, Miceli M, Zoli A et al (2014) Body weight, gender and response to TNF-\u03b1 blockers in axial spondyloarthritis. Rheumatology (Oxford) 53(5):875\u2013881","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3183_CR22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3899\/jrheum.140673","volume":"42","author":"YM Pers","year":"2015","unstructured":"Pers YM, Godfrin-Valnet M, Lambert J, Fortuet C, Constant E, Mura T, Pallot-Prades B, Jorgensen C, Maillefert JF, Marotte H et al (2015) Response to tocilizumab in rheumatoid arthritis is not influenced by the body mass index of the patient. J Rheumatol 42(4):580\u2013584","journal-title":"J Rheumatol"},{"issue":"9","key":"3183_CR23","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3183_CR24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"J Smolen","year":"2010","unstructured":"Smolen J, Landew\u00e9 R, Breedveld F, Dougados M, Emery P, Gaujoux-Viala C et al (2010) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69(6):964\u2013975","journal-title":"Ann Rheum Dis"},{"issue":"Suppl2","key":"3183_CR25","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1136\/annrheumdis-2013-203348","volume":"72","author":"D Furst","year":"2013","unstructured":"Furst D, Keystone E, So A, Braun J, Breedveld F, Burmester G, De Benedetti F, D\u00f6rner T, Emery P, Fleischmann R et al (2013) Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012. Ann Rheum Dis 72(Suppl2):ii2\u2013ii34","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3183_CR26","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K","volume":"41","author":"AM Gestel van","year":"1998","unstructured":"van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41(10):1845\u20131850","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3183_CR27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/keq230","volume":"50","author":"D Rooy de","year":"2011","unstructured":"de Rooy D, van der Linden M, Knevel R, Huizinga T, Van der Helm-van Mil A (2011) Predicting arthritis outcomes\u2014what can be learned from the Leiden early arthritis clinic? Rheumatology (Oxford) 50(1):93\u2013100","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3183_CR28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/art.30291","volume":"63","author":"E Neumann","year":"2011","unstructured":"Neumann E, Frommer K, Vasile M, Muller-Ladner U (2011) Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases? Arthritis Rheum 63(5):1159\u20131169","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3183_CR29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","volume":"49","author":"MJ Hanley","year":"2010","unstructured":"Hanley MJ, Abernethy DR, Greenblatt DJ (2010) Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 49(2):71\u201387","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"3183_CR30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","volume":"25","author":"P Dandona","year":"2004","unstructured":"Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25(1):4\u20137","journal-title":"Trends Immunol"},{"issue":"10","key":"3183_CR31","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J, Fu L, Shi J, Chen X, Li Y, Ma B, Zhang Y (2013) The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies. PLoS One 8(10), e78151","journal-title":"PLoS One"},{"issue":"4","key":"3183_CR32","doi-asserted-by":"crossref","first-page":"R160","DOI":"10.1186\/ar3900","volume":"14","author":"A Stavropoulos-Kalinoglou","year":"2012","unstructured":"Stavropoulos-Kalinoglou A, Metsios G, Panoulas V, Nightingale P, Koutedakis Y, Kitas G (2012) Anti-tumour necrosis factor alpha therapy improves insulin sensitvity in normal-weight but not in obese patients with rheumatoid arthritis. Arthritis Res Ther 14(4):R160","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3183_CR33","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1210\/jcem.86.3.7305","volume":"86","author":"JM Fernandez-Real","year":"2001","unstructured":"Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, Ricart W (2001) Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86(3):1154\u20131159","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"3183_CR34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014328","volume":"5","author":"O Schultz","year":"2010","unstructured":"Schultz O, Oberhauser F, Saech J, Rubbert-Roth A, Hahn M, Krone W, Laudes M (2010) Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases. PLoS One 5(12), e14328","journal-title":"PLoS One"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3183-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3183-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3183-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:59:29Z","timestamp":1559120369000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3183-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["3183"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3183-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,22]]}}}